|
Catalog Number FG540000 |
Device Problems
Display or Visual Feedback Problem (1184); Poor Quality Image (1408)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 08/28/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
The hardware investigation has begun but it has not been completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
|
Event Description
|
It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a carto® 3 system and a map shift issue occurred.It was reported by the caller, the bwi representative, that while creating the matrix with the octaray catheter, they started on ablation, continued to map while in the left atrium, and once they started to burn the left pulmonary vein on the ridge, they noticed a significant map shift.The caller reported that the map looked like it shifted up by approximately 20mm.The caller reported that electrode 2 was sometimes black, but they could create matrix.To troubleshoot the caller checked the metal values and made sure the spu was far enough away from everything without resolution.The caller created a new map, they experienced no further shifts, and the procedure was continued.On (b)(6) 2023, additional information received indicated there were no errors provided by the system.They observed that the octaray catheter was outside of the initial map created.The issue was seen during ablation.No cardioversion or patient movement.The patient was on ¿jet¿ the entire case.This event was originally considered nonreportable, however, bwi became aware of additional information on (b)(6) 2023 and have reassessed the event as an mdr reportable malfunction for the map shift.
|
|
Manufacturer Narrative
|
It was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a carto® 3 system and a map shift issue occurred.It was reported by the caller, the bwi representative, that while creating the matrix with the octaray catheter, they started on ablation, continued to map while in the left atrium, and once they started to burn the left pulmonary vein on the ridge, they noticed a significant map shift.The caller reported that the map looked like it shifted up by approximately 20mm.The caller reported that electrode 2 was sometimes black, but they could create matrix.To troubleshoot the caller checked the metal values and made sure the spu was far enough away from everything without resolution.The caller created a new map, they experienced no further shifts, and the procedure was continued.On 31-aug-2023, additional information received indicated there were no errors provided by the system.They observed that the octaray catheter was outside of the initial map created.The issue was seen during ablation.No cardioversion or patient movement.The patient was on ¿jet¿ the entire case.Device evaluation details: it was confirmed that the issue was not duplicated in the following case.The system is ready for use.An investigation was initiated by the manufacturer to investigate the issue.The provided data was insufficient to conduct investigation, no more data was available.The manufacturing record evaluation was performed on carto 3 #14692, and no internal actions related to the reported complaint condition were identified.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# pc-(b)(4).
|
|
Search Alerts/Recalls
|
|
|